[Mutagenicity testing of chemical compounds].
D000022:Abortion, Spontaneous; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D002869:Chromosome Aberrations; D003520:Cyclophosphamide / Q000633:toxicity; D004341:Drug Evaluation; D005260:Female; D005854:Germ Cells / Q000187:drug effects; D006801:Humans; D006834:Hydrazines / Q000633:toxicity; D007231:Infant, Newborn; D007538:Isoniazid / Q000633:toxicity; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D008722:Methods; D008727:Methotrexate / Q000633:toxicity; D051379:Mice; D009153:Mutagens / Q000633:toxicity*; D009154:Mutation; D009602:Nitrosamines / Q000633:toxicity; D011247:Pregnancy; D051381:Rats; D013091:Spermatogenesis / Q000187:drug effects; D013723:Teratogens / Q000633:toxicity; D014228:Triaziquone / Q000633:toxicity
D006834:Hydrazines; D009153:Mutagens; D009602:Nitrosamines; D013723:Teratogens; D003520:Cyclophosphamide; D014228:Triaziquone; D007538:Isoniazid; D008727:Methotrexate
Die Testung von Fremdstoffen auf Mutagenität